AZN financial statements
The full income statement, balance sheet, and cash-flow statement for AstraZeneca PLC (AZN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 58.7B+8.6% | 54.1B+18.0% | 45.8B+3.3% | 44.4B+18.5% | 37.4B+40.6% | |
| 48.1B+9.7% | 43.9B+16.8% | 37.5B+17.5% | 32.0B+27.9% | 25.0B+17.2% | ||
| Cost of revenue | 10.6B+4.2% | 10.2B+23.5% | 8.27B-33.3% | 12.4B-0.4% | 12.4B+134.7% | |
| Research & development | 14.2B+4.8% | 13.6B+24.2% | 10.9B+12.0% | 9.76B+0.3% | 9.74B+62.5% | |
| Operating income | 13.7B+37.4% | 10.0B+22.1% | 8.19B+118.1% | 3.76B+255.8% | 1.06B-79.5% | |
| Interest expense | 1.69B-2.8% | 1.74B+7.1% | 1.63B+20.8% | 1.35B+3.5% | 1.30B-0.5% | |
| Pre-tax income | 12.4B+42.7% | 8.69B+26.0% | 6.90B+175.8% | 2.50B+1043.8% | -265M-106.8% | |
| Income tax | 2.17B+31.5% | 1.65B+75.9% | 938M+218.4% | -792M-108.4% | -380M-149.2% | |
| 10.2B+45.3% | 7.04B+18.1% | 5.96B+81.0% | 3.29B+2763.5% | 115M-96.3% | ||
| Net income to common | 10.2B+45.3% | 7.04B+18.1% | 5.96B+81.1% | 3.29B+2835.7% | 112M-96.5% | |
| $6.54+45.3% | $4.50+18.1% | $3.81+80.6% | $2.11+2537.5% | $0.08-96.7% | ||
| EPS (basic) | $6.60+45.4% | $4.54+18.2% | $3.84+81.1% | $2.12+2550.0% | $0.08-96.7% | |
| Weighted-avg shares (basic) | 1.55B+0.0% | 1.55B+0.1% | 1.55B+0.1% | 1.55B+9.2% | 1.42B+8.1% | |
| Weighted-avg shares (diluted) | 1.56B-0.1% | 1.56B+0.1% | 1.56B+0.1% | 1.56B+9.3% | 1.43B+8.7% | |
| Dividends per share | $3.13+5.4% | $2.97+2.4% | $2.90+0.0% | $2.90+3.6% | $2.80+0.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 28.7B+11.2% | 25.8B+3.1% | 25.1B+10.9% | 22.6B-13.9% | 26.2B+34.3% | ||
| Cash & equivalents | 5.71B+4.1% | 5.49B-6.0% | 5.84B-5.3% | 6.17B-2.6% | 6.33B-19.2% | |
| Accounts receivable | 15.2B+17.0% | 13.0B+7.0% | 12.1B+15.3% | 10.5B+9.1% | 9.64B+37.3% | |
| Inventory | 6.56B+24.0% | 5.29B-2.5% | 5.42B+15.4% | 4.70B-47.7% | 8.98B+123.2% | |
| 114B+9.6% | 104B+2.9% | 101B+4.8% | 96.5B-8.4% | 105B+57.9% | ||
| Property, plant & equipment | 13.0B+26.4% | 10.3B+9.0% | 9.40B+10.5% | 8.51B-7.4% | 9.18B+11.3% | |
| Goodwill | 21.2B+1.0% | 21.0B+4.9% | 20.0B+1.2% | 19.8B-0.9% | 20.0B+68.8% | |
| Total non-current assets | 85.4B+9.1% | 78.2B+2.8% | 76.1B+2.9% | 73.9B-6.6% | 79.1B+67.7% | |
| Total current liabilities | 30.6B+9.9% | 27.9B-8.8% | 30.5B+16.2% | 26.3B+16.4% | 22.6B+11.3% | |
| 65.4B+3.5% | 63.2B+2.0% | 62.0B+4.3% | 59.4B-10.1% | 66.1B+29.3% | ||
| Long-term debt | 24.7B-6.8% | 26.5B+18.5% | 22.4B-2.6% | 23.0B-18.4% | 28.1B+60.7% | |
| 48.7B+19.3% | 40.8B+4.2% | 39.1B+5.7% | 37.0B-5.7% | 39.3B+151.4% | ||
| Total equity incl. non-controlling | 48.7B+19.2% | 40.9B+4.4% | 39.2B+5.7% | 37.1B-5.7% | 39.3B+151.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash from operations | 14.6B+22.9% | 11.9B+14.7% | 10.3B+5.5% | 9.81B+64.5% | 5.96B+24.3% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 15.0M-99.8% | 6.49B+70.1% | 3.82B | 0.00-100.0% | 12.9B+335.6% | |
| Long-term debt repaid | 2.03B-56.4% | 4.65B-5.9% | 4.94B+288.8% | 1.27B-73.3% | 4.76B+195.8% | |
| Common stock issued | 40.0M+5.3% | 38.0M+15.2% | 33.0M+13.8% | 29.0M+0.0% | 29.0M-3.3% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 4.85B+5.3% | 4.60B+2.6% | 4.49B+0.0% | 4.49B+15.5% | 3.88B+5.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| P/E | 28.1×-3.5% | 29.1×-54.4% | 63.8×-96.2% | 1695.0×+16.4% | 1456.3×+3454.0% | |
| Earnings yield | 3.6%+3.6% | 3.4%+119.2% | 1.6%+2555.1% | 0.06%-14.1% | 0.07%-97.2% | |
| Dividend yield | 1.7%-24.9% | 2.3%+5.3% | 2.2%+0.7% | 2.1%-11.0% | 2.4%-14.2% | |
| Source filing | 20-F | 20-F | 20-F | 20-F | 20-F |
About this data
Source: AZN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AZN filings on SEC EDGAR → Not investment advice.